Biofarm S.A. (BVB:BIO)

Market Cap	1.44B +114.7%
Revenue (ttm)	316.75M +2.1%
Net Income	100.84M +17.1%
EPS	0.09 +16.2%
Shares Out	985.37M
PE Ratio	15.82
Forward PE	n/a
Dividend	0.04 (2.88%)
Ex-Dividend Date	Jun 29, 2026

Volume	61,943
Open	1.450
Previous Close	1.450
Day's Range	1.450 - 1.460
52-Week Range	0.724 - 1.475
Beta	0.50
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About Biofarm

Biofarm S.A. manufactures and sells medicines in Romania. The company offers a portfolio of products covering therapeutic areas, such as antiallergics, cardiovascular and circulatory, analgesics and antipyretics, dermatology, digestive and metabolic, endocrine, genitourinary, multivitamins, ophthalmology, musculoskeletal, respiratory and ENT, and neurology. It provides prescription and non-prescription medicines, food supplements, medical devices, cosmetics, medical devices, and other products. The company also exports its products in Albania, ...

• Industry: Pharmaceutical Preparations
• Founded: 1921
• Employees: 374
• Stock Exchange: Bucharest Stock Exchange
• Ticker Symbol: BIO

Financial Performance

In 2025, Biofarm's revenue was 319.33 million, an increase of 11.36% compared to the previous year's 286.77 million. Earnings were 100.63 million, an increase of 35.27%.